International Journal of Infection Prevention invites high quality submissions that advance infection prevention, healthcare epidemiology, and antimicrobial stewardship across clinical and community settings. We welcome original research, systematic reviews, and implementation studies that reduce infection risk and improve patient safety.

Our editorial focus prioritizes rigorous study design, transparent reporting, and measurable impact on prevention practices and policy.

• Healthcare-associated infection surveillance and prevention bundles
• Antimicrobial stewardship and resistance mitigation strategies
• Outbreak investigation, response, and containment modeling
• Infection control in surgical, ICU, and long-term care settings
• Vaccination programs and implementation effectiveness
• Environmental hygiene, disinfection, and sterilization science
• WASH and community infection prevention initiatives
• Occupational exposure, PPE, and safety protocols
• Diagnostics, screening, and rapid testing workflows
• One Health approaches and zoonotic spillover prevention
• Behavior change, compliance measurement, and IPC training
• Data-driven surveillance systems and digital reporting tools

• Outbreak reports with clear response timelines
• Implementation science and quality improvement studies
• Surveillance reports and antimicrobial use analyses
• Practice or policy briefs grounded in evidence

Successful submissions present a clear prevention question, robust methodology, and transparent reporting of case definitions and denominators. We value studies that demonstrate measurable reductions in infection risk or improvements in compliance and safety.

Authors should document surveillance protocols, intervention fidelity, and outcome definitions to support reproducibility and real-world adoption.

• Clear case definitions and standardized denominators
• Validated surveillance methods and data quality checks
• Appropriate statistical analysis and handling of confounders
• Interpretation that links findings to prevention decisions

Submissions undergo editorial screening for scope fit, methodological rigor, and reporting completeness. Qualified manuscripts move to single blind peer review with subject matter experts.

IJIP operates under an open access model to ensure infection prevention research is discoverable and reusable. APCs are applied after acceptance and support peer review, production, and archiving services.

Membership options and affordable APC waivers are available for eligible authors. Contact the editorial office at [email protected] for guidance.

• Scope fit confirmed for infection prevention research
• Case definitions and denominators documented
• Data availability statement included
• Ethics approvals and consent described
• Cover letter explains novelty and prevention relevance

IJIP prioritizes submissions that demonstrate measurable prevention outcomes and actionable improvements in clinical or community settings. We look for clear definitions, transparent denominators, and evidence that interventions are feasible, scalable, and ethically implemented. Strong submissions connect data to decision making, show how interventions reduce risk, and explain how results can be replicated across different facilities and populations.

Implementation science, stewardship, and surveillance studies should include baseline context, resource requirements, and reporting of adherence. We value studies that describe how training, leadership, and workflow design influence infection prevention performance, as well as work that addresses equity and access in low resource settings.

To support rigorous peer review, authors should present concise methodology details and identify limitations, including any constraints in data collection, sampling, or follow up. Clear reporting builds trust in outcomes and helps infection prevention teams adapt findings responsibly.

• Define case definitions and align with CDC or WHO guidance.
• Report denominators and surveillance periods for rate calculations.
• Describe intervention components and implementation fidelity checks.
• Include antimicrobial stewardship protocols and compliance tracking.
• Report PPE, isolation, or cohorting practices used in the study.
• Detail environmental cleaning methods and verification procedures.
• State laboratory diagnostics, testing cadence, and turnaround time.
• Provide risk adjustment variables for comparative analyses.
• Describe training, behavior change tools, and audit feedback loops.
• Report adverse events or unintended consequences of interventions.
• Include data availability statements and access conditions.
• Clarify how findings translate across high and low resource settings.

For digital surveillance, alert systems, and electronic health record interventions, describe integration steps, alert thresholds, and how teams handled workflow disruption or alert fatigue. When studies involve community or public health programs, outline engagement strategies, communication channels, and partnerships that sustained participation over time. Where possible, include cost considerations and resource requirements so readers can assess feasibility.

We also encourage evaluations of equity focused interventions that address disparities in infection risk. Clearly explain how populations were selected, how access barriers were mitigated, and how outcomes differed across demographic or geographic groups.

To support reproducibility, include information on data governance, privacy safeguards, and how sensitive patient data were handled. Describe quality assurance steps for data extraction and any validation checks. If your study uses modeling or simulations, state the assumptions, sensitivity analyses, and validation against real world data.

These standards help reviewers assess reproducibility and ensure published work can be translated into safer clinical practice and stronger infection prevention policy. They also help readers benchmark interventions, justify resource allocation, and sustain long term improvements. This clarity supports consistent implementation across hospitals and community programs.

IJIP is committed to rigorous, transparent publishing in infection prevention and control. We emphasize reproducible surveillance methods, clear reporting of case definitions, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in infection prevention science and implementation.